Bristol-Myers Squibb (BMY) Stock Moves -1.59%: What You Should KnowZacks Investment Research • 03/05/20
Bristol-Myers Squibb: Market Uncertainty Makes For A (Potential) Buying OpportunitySeeking Alpha • 02/29/20
Bristol-Myers Squibb (BMY) Stock Moves -0.87%: What You Should KnowZacks Investment Research • 02/28/20
Bristol-Myers' Liso-Cel Given Priority Review, Ability To Change Scope Of TreatmentSeeking Alpha • 02/26/20
Bristol-Myers Squibb Makes Case For Success Of Opdivo With Latest Long-Term Kidney Cancer DataSeeking Alpha • 02/21/20
7 High-Yield Stocks I'm Buying For My Retirement Portfolio In This Red-Hot MarketSeeking Alpha • 02/18/20
5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher24/7 Wall Street • 02/11/20
Bristol-Myers Posts Bullish Growth — But Is It Time To Add BMY Stock?Investors Business Daily • 02/07/20
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/06/20